Gene expression profiles of the high-risk group correlated positively with the upregulation of CSC markers, CD24, CD44, CD20, FOXM1, and EpCAM, and significant enrichment of other ESC signatures, indicating that these were tumor-promoting targets. This evidence concerns the gene CD24 and neoplasm.